6th World Parkinson Congress
Plenary Sessions
6th World Parkinson Congress
The Role of Alpha-Synuclein and Co-Pathology in Cognitive and Non-Motor Symptoms
FEATURING
Georgina Aldridge
- 10 views
- September 15, 2023
6th World Parkinson Congress
Co-Pathologies and Parkinson’s: What’s it All Mean to Those Living With PD?
FEATURING
Soania Mathur
- 5 views
- September 15, 2023
6th World Parkinson Congress
Prevalence of Co-Pathologies in Parkinson’s Disease
FEATURING
Lauren Walker
- 5 views
- September 15, 2023
6th World Parkinson Congress
Contributions of Co-Pathologies in Activating the Immune Response in PD Patients
FEATURING
Ashley Harms
- 4 views
- September 15, 2023
6th World Parkinson Congress
How Can Imaging Track PD?
FEATURING
Thilo Van Eimeren
- 105 views
- September 15, 2023
6th World Parkinson Congress
Self-Tracking: To Track or not to Track?
FEATURING
Sara Riggare
- 9 views
- September 15, 2023
6th World Parkinson Congress
Why Should we Track Parkinson’s Disease?
FEATURING
Bastiaan R. Bloem
- 385 views
- September 1, 2023
- 5
6th World Parkinson Congress
How Can we Track PD Using Blood and Tissue-Based Biomarkers?
FEATURING
David Standaert
- 19 views
- September 1, 2023
6th World Parkinson Congress
Best Options for Nutrition in Parkinson’s
FEATURING
Silke Appel-Cresswell
- 129 views
- September 1, 2023
6th World Parkinson Congress
What do Subtypes Mean for People with Parkinson’s?
FEATURING
Jonny Acheson
- 10 views
- September 1, 2023
6th World Parkinson Congress
Different α-synuclein Strains in Parkinson’s Disease Brains
FEATURING
Markus Zweckstetter
- 16 views
- August 29, 2023
6th World Parkinson Congress
Brain-First or Body-First Parkinson’s Disease
FEATURING
Per Borghammer
- 52 views
- August 29, 2023
- 1